Status:
UNKNOWN
Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction in Vietnamese HIV-Infected Patients
Lead Sponsor:
National Center for Global Health and Medicine, Japan
Conditions:
HIV Infection
Renal Function Disorder
Eligibility:
All Genders
20+ years
Brief Summary
This study is to investigate clinical utility of beta2 microglobulin as an early marker for renal dysfunction caused by Tenofovir in Vietnamese HIV-infected patients.
Detailed Description
An observational study to investigate clinical utility of beta2 microglobulin as an early marker for renal dysfunction caused by Tenofovir in Vietnamese HIV-infected patients.
Eligibility Criteria
Inclusion
- HIV-infected patients in the NHTD -ACC cohort who are under cART or will start cART and can provide written informed consents.
Exclusion
- HIV-infected patients who drop out of treatment within 6 months from the entry.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2017
Estimated Enrollment :
1800 Patients enrolled
Trial Details
Trial ID
NCT02256579
Start Date
October 1 2014
End Date
March 1 2017
Last Update
October 3 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.